Introduction
There are many factors regulating birth weight, including gestational age at delivery, maternal age, body mass index (BM ), parity, ethnicity, habits (smoking, etc.), and medical (diabetes mellitus, etc.) conditions 1-3 . Abnormal fetal growth may increase neonatal morbidity and mortality. The risks of stillbirth, chronic lung disease, necroti ing enterocolitis, and neurodevelopmental problems in childhood, as well as hypertension, vascular disease, and diabetes in adulthood increase in small for gestational age (SGA) newborns (defined as less than 10th percentile birth weight) 4,5 . Similarly, large for gestational age ( GA) newborns (defined as greater than 90th percentile birth weight) have an increased risk of delivery complications such as shoulder dystocia, other birth injuries, and cesarean delivery, as well as obesity, cardiovascular disease, and metabolic complications in adulthood 6,7 . Early determination of fetal growth abnormalities may be beneficial for obstetricians in order to take essensial precautions. owever, today s screening modalities are limited by varying sensitivities and high false positive rates. Thus early prediction of fetal growth abnormalities is still challenging. Placental volume and maternal biochemistry re ecting placental function at 11-13 weeks of gestation have been studied in order to determine whether they have any predictive role for birth weight abnormalities 8-10 . But the results are highly variable and controversial. n our study, we aimed to investigate whether first trimester biochemical parameters used to screen for Down syndrome were related to birth weight in a Turkish population and to determine the prediction accuracy of these parameters for SGA and GA newborns.
Material and Method
This retrospective study was approved by the instituional review board of ekai Tahir Burak oman s ealth Education and esearch ospital, a tertiary referral research hospital located in the central region of Turkey. Pregnant women who had undergone first-trimester aneuploidy screening by nuchal translucency (NT) thickness, maternal serum free beta-human chorionic gonadotropin (f -hCG), and pregnancy-associated plasma protein-A (PAPP-A) between anuary 2014 and anuary 2015 at the bstetrics Department of the hospital participated. omen who had multiple gestation pregnancy, preexisting diabetes, detected fetal chromosomal or major structural defects, miscarriage or fetal death before 24 weeks, diagnosed gestational diabetes, or intrauterine growth restriction in their follow-up and those with insu cient data were excluded. All data were collected from hospital records. Between the 11th and 14th week of gestation, transabdominal or transvaginal (if necessary) ultrasonographic assessment of all pregnancies was performed for the measurements of fetal crown-rump length (C ). hen a C between 45 and 84 mm was detected, NT thicknesses were also measured by trained obstetricians. Furthermore, at that time maternal serum PAPP-A and f -hCG levels were measured by automatic uorometric immunoassays. esults were reported as multiples of the median (MoM) adjusted for gestational age, maternal weight, and smoking status. Smokers were defined as those who had smoked at a continuous rate of at least one cigarette per day, starting at conception or earlier.
At delivery, birth weight was converted into a percentile for gestational age at delivery and by gender according to the Turkish population data 11 . Gestational ages at delivery were adjusted using the gestational age and C obtained during NT measurement. Newborns with a birth weight of 10th percentile were identified as SGA, newborns with a birth weight 90th percentile as GA, and those in the 10th-90th percentile as average for gestational age (AGA). Statistical analysis was performed using the using SPSS soware version 17.0 (SPSS nc., Chicago, ). Kolmogorov Smirnov test was performed to determine whether the data were sampled from a normal distribution. Continuous variables with normal distribution are presented as mean standard deviation. For these variables, the di erence between the groups was evaluated by one-way analysis of variance test. hen the p value from the variance analysis was statistically significant, posthoc Tukey test was used to determine which group di ered from which others. Categorical variables were analy ed with the Chi-s uare test. eceiver-operating characteristic ( C) curves were constructed to calculate the sensitivity, specificity, positive predictive value (PP ), negative predictive value (NP ), and accuracy for di erent measures of maternal serum PAPP-A levels in predicting SGA and GA newborns. Correlations between birth weight and first trimester markers were estimated using the Spearman s correlation coe cient. p 0.05 was considered statistically significant.
Results
For this study, 1558 singleton pregnancies with a live fetus who had undergone first trimester aneuploidy screening were reviewed. Because of miscarriage and fetal death before 24 weeks of gestation, 45 women were excluded. 33 women were excluded because of detected fetal chromosomal or major structural defects. 124 women were excluded due to insu cient data. The final study population included 1356 screened singleton pregnancies with their live born infants. f these newborns, 138 (10.2 ) were SGA, 246 (18.1 ) were GA, and 972 (71.7 ) were AGA. The characteristics of SGA, GA, and AGA groups are listed in Table 1 . n the SGA group, maternal serum PAPP-A level and birth weight were significantly lower than the other groups. n contrast, the GA group had statistically higher serum PAPP-A levels and birth weights than the AGA group. Maternal serum f -hCG level was lower in the SGA group than the AGA and GA groups, but the di erences between the groups were not statistically significant. There was also no di erence between the groups with regard to other variables listed in Table 1 . The correlations between the first trimester markers and birth weight are shown in Table 2 . Maternal serum PAPP-A level was significantly but weakly correlated to birth weight, whereas maternal serum f -hCG levels, NT, and C measurements were not significantly correlated.
C curve for maternal serum PAPP-A level in predicting SGA newborn is displayed in Figure 1 (Table 3 ). Figure 2 shows the C curve for maternal serum PAPP-A level in predicting an GA newborn. The curve constructed for PAPP-A level was above the 45 line, showing that there was a weak but significant relationship between these two variables (area under the curve 0.611 standard error 0.054 95 , confidence interval 0.505 0.717 p 0.026). The best cut-o value of maternal serum PAPP-A level for the prediction of GA newborn was 1.005 MoM with a sensitivity of 61.0 , specificity of 62.7 , PP of 26.6 , NP of 87.9 , and accuracy of 62.4 (Table 3) . Discussion n our retrospective cohort study, maternal serum PAPP-A levels measured by the first trimester aneuploidy screening was weakly associated with birth weight. ,Pregnant women with low PAPP-A levels were more likely to have an SGA newborn while women with high levels were more likely to have an GA newborn. owever, there were no relationships found between maternal serum f -hCG level, ultrasonographic measurement of NT thickness, and birth weight. PAPP-A is a protease in glycoprotein structure, produced by syncytiotrophoblast during pregnancy its concentration in the maternal circulation increases as pregnancy progresses 12 . By means of its proteolytic activity, PAPP-A acts as a regulatory protein in the insulin-like growth factor system ( GF) 13 . t has been suggested that the GF system modulates trophoblast invasion and cell growth 14 . Therefore PAPP-A appears to be important for placental formation and regulation of fetal growth. n the literature, it has been consistently suggested that low PAPP-A level is a reliable predictor for SGA delivery 8,10,15 . owever, studies investigating the association between high PAPP-A levels and birth weight have reported con icting results. Namely, some reports have indicated that there is a relationship between high PAPP-A level and GA newborn 9,15 , while others have found no association 16,17 . As mentioned above, our results revealed that first trimester PAPP-A level is weakly and positively associated with birth weight in uncomplicated pregnancies. n our study, a single PAPP-A level of 0.795 MoM predicted SGA newborn with a sensitivity of 73.9 , specificity of 63.1 , PP of 18.5 , NP of 95.5 , and an accuracy of 64.2 . This high NP with relatively low sensitivity re ects that measurement of PAPP-A level during the first trimester is beneficial in determining women who are unlikely to deliver SGA newborns. n the other hand, a PAPP-A level of 1.005 MoM was identified as the optimal cut-o point for the prediction of an GA newborn with a sensitivity of 61.0 , specificity of 62.7 , PP of 26.6 , NP of 87.9 , and accuracy of 62.4 . Similarly, this cut-o point with high NP and low sensitivity is an e ective indicator of women who are unlikely to deliver an GA newborn. The overlap in PAPP-A levels between the AGA group 0.94 (0.14-3.18) MoM and the GA group 1.16 (0.23-3.10) MoM might decrease the sensitivity of maternal serum PAPP-A level in predicting a GA newborn. Plasma filtrate from maternal circulation is the main nutrition source of the embryo during the mid-first trimester 18 . As serum PAPP-A level increases, GF-binding protein-3 levels decreases 13 . GF-binding protein-3 levels are inversely asssociated with capillary permeability 19 . Thus, due to the increase alues were given as mean standard deviation median (minimum-maximum) or number ( ) SGA: Small for gestational age AGA: Appropriate for gestational age GA:
arge for gestational age C : Crown-rump length NT: nuchal translucency f -hCG:free beta-human chorionic gonadotropin PAPP-A: Pregnancy associated plasma protein-A Mom: Multiples of the expected median p 0.05 was considered statistically significant. of maternal serum PAPP-A level, capillary permeability increases at mid-first trimester, enhancing the plasma filtrate taken by the embryo. This could result in an increase of fetal growth. owever, this association still needs to be proven. Some toxic agents such as tobacco smoke might damage the blood ow to the placenta resulting in some placental necrosis areas occurring. This may result in insu cient PAPP-A expression and GF axis disorders, reduced active transport of essential nutrients to the fetus, and may lead to fetal growth failure. n our study, smoking rates in the groups were statistically similar we think this eliminates bias about the impact of smoking when comparing PAPP-A levels between the groups. n obstetrical practice, the predictive role of first trimester maternal serum f -hCG level for birth weight is still controversial. Several studies reported a significant relationship between f -hCG and birth weight 3,20 , whereas others demonstrated none 21,22 , possibly because of di erent variables format ( / ml, MoM, or percentile). ur findings did not confirm the relationship between these two parameters. Thus, we believe that further studies are needed to clarify this topic. n our study, we observed no relationship between NT thickness and birth weight, similar to some previous studies 1,3,23 and contrary to others 16,24,25 . e speculate that there may be several factors that a ect the NT in a euploid fetus genetic, structural, and developmental that cannot be detected during the antenatal period. Therefore, this topic remains to be explained with additional and larger prospective studies. This study has some limitations. The main limitation is its retrospective design. Given this study design, some clinical details including placental volume, placental su ciency, and pathological investigation of placenta were not included in the study. This study also has a relatively small study population. And lastly, this study included data from a single center in Turkey, so cannot be generali ed to other populations. n conclusion, among the parameters used for first-trimester aneuploidies screening, only maternal serum PAPP-A levels may contribute to the prediction of birth weight in uncomplicated pregnancies. owever, due to low sensitivity, this parameter is not a clinically relevant screening test for prediction of pregnancies at risk of SGA or GA delivery. Nevertheless, further prospective studies are needed to justify our results and to suggest more definitive recommendations.
